Viewing Study NCT03076918


Ignite Creation Date: 2025-12-25 @ 4:40 AM
Ignite Modification Date: 2026-02-09 @ 2:42 AM
Study NCT ID: NCT03076918
Status: TERMINATED
Last Update Posted: 2018-05-18
First Post: 2017-03-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy
Sponsor: University Hospital, Lille
Organization:

Study Overview

Official Title: A Phase II Study Evaluating the Non-inferiority of the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy (PDT)
Status: TERMINATED
Status Verified Date: 2018-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: decision of the investigator in the face of new scientific knowledge
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Flexithera
Brief Summary: This study compares the efficacy and tolerance of a new device (FLEXITHERALIGHT) for photodynamic therapy in the treatment of keratosis actinic in comparison of classical PDT with Aktilite®.
Detailed Description: The study is an intraindividual comparison of two methods. The number of subjects to be enrolled is 47 patients. All participants will receive both two treatments in a single visit : a first period of 2.5 hours of illumination with FLEXITHERALIGHT device followed by a continuous red light Spectrum (between 7 and 10 minutes) with Aktilite® after an appropriate incubation of methyl aminolevulinate).

Patients will complete a pain assessment scale after receiving both treatments, then, 3 follow up visits will be scheduled.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
2013-A01096-39 OTHER ID-RCB number, ANSM View